NCT01151059 - Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL

Trivalent subunit inactivated flu vaccine, Formulation 2010-2011

This phase II is performed as a multicenter study site in non-elderly adult and elderly subjects. Enrolled subjects received one single IM dose of trivalent subunit inactivated flu vaccine during the vaccination visit, according to the study protocol (follow-up period: till day 22).

Trial Locations (5)

16132

Dipartimento di Scienze della Salute Università di Genova Via Pastore, 1, Genova

20127

Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, 20, Milan

44100

Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Via Fossato di Mortara, 64/b, Ferrara

66034

Centro Satellite. ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37, Lanciano

66100

Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini, Chieti